| Dr Bradley T Rankin, MD | |
|
2312 Kentucky Avenue, Paducah, KY 42003 | |
| (270) 442-5151 | |
| (855) 656-7325 |
| Full Name | Dr Bradley T Rankin |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 41 Years |
| Location | 2312 Kentucky Avenue, Paducah, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457355893 | NPI | - | NPPES |
| 64257215 | Medicaid | KY | |
| P00824071 | Other | KY | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 25721 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Paducah | Paducah, KY | Hospital |
| Lourdes Hospital | Paducah, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Psf Pllc | 1557265543 | 98 |
News Archive
FAU has demonstrated its strength in research once again: the University is conducting a new research project together with Siemens Healthcare GmbH, Universitätsklinikum Erlangen and other European partners in which researchers will develop an innovative hybrid device that combines different medical imaging technologies and will help stroke patients in particular to receive quicker diagnosis and treatment.
Higher intake of omega-3 fatty acids was associated with better sleep quality and a decrease in depressive symptoms in lupus patients, among other patient-reported outcomes, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.
The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily on a 2-week treatment cycle. The study demonstrates that both formulations were superior to placebo, and that imiquimod 3.75% on a daily 2-week treatment cycle is superior to imiquimod 2.5% in treating actinic keratosis (AK) on a large surface area - the face or balding scalp.
U.S. Global AIDS Coordinator Eric Goosby on Tuesday in an interview with Reuters discussed how as part of its new strategy PEPFAR will aim to "to transform healthcare in some of the world's poorest countries," the news agency writes.
› Verified 1 days ago
| Entity Name | Psf Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881785947 PECOS PAC ID: 1557265543 Enrollment ID: O20031121000240 |
News Archive
FAU has demonstrated its strength in research once again: the University is conducting a new research project together with Siemens Healthcare GmbH, Universitätsklinikum Erlangen and other European partners in which researchers will develop an innovative hybrid device that combines different medical imaging technologies and will help stroke patients in particular to receive quicker diagnosis and treatment.
Higher intake of omega-3 fatty acids was associated with better sleep quality and a decrease in depressive symptoms in lupus patients, among other patient-reported outcomes, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.
The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily on a 2-week treatment cycle. The study demonstrates that both formulations were superior to placebo, and that imiquimod 3.75% on a daily 2-week treatment cycle is superior to imiquimod 2.5% in treating actinic keratosis (AK) on a large surface area - the face or balding scalp.
U.S. Global AIDS Coordinator Eric Goosby on Tuesday in an interview with Reuters discussed how as part of its new strategy PEPFAR will aim to "to transform healthcare in some of the world's poorest countries," the news agency writes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bradley T Rankin, MD 9800 Shelbyville Rd, Suite #220, Louisville, KY 40223-2992 Ph: (502) 429-8585 | Dr Bradley T Rankin, MD 2312 Kentucky Avenue, Paducah, KY 42003 Ph: (270) 442-5151 |
News Archive
FAU has demonstrated its strength in research once again: the University is conducting a new research project together with Siemens Healthcare GmbH, Universitätsklinikum Erlangen and other European partners in which researchers will develop an innovative hybrid device that combines different medical imaging technologies and will help stroke patients in particular to receive quicker diagnosis and treatment.
Higher intake of omega-3 fatty acids was associated with better sleep quality and a decrease in depressive symptoms in lupus patients, among other patient-reported outcomes, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.
The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily on a 2-week treatment cycle. The study demonstrates that both formulations were superior to placebo, and that imiquimod 3.75% on a daily 2-week treatment cycle is superior to imiquimod 2.5% in treating actinic keratosis (AK) on a large surface area - the face or balding scalp.
U.S. Global AIDS Coordinator Eric Goosby on Tuesday in an interview with Reuters discussed how as part of its new strategy PEPFAR will aim to "to transform healthcare in some of the world's poorest countries," the news agency writes.
› Verified 1 days ago
Dr. Francis J Block Iii, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 150 Brett Chase, Suite A, Paducah, KY 42003 Phone: 270-534-9513 Fax: 270-534-9515 |